GPI-Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications

GPI-Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications

<strong>Background:</strong> We have previously reported the aberrant expression of Fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). Although FMOD has been considered as a cytoplasmic or secretory protein, we discovered the cell surface expression of FMOD in leuke...

Full description

Bibliographic Details
Main Authors: Lia Farahi, Fatemeh Ghaemimanesh, Saeideh Milani, Seyed Mohsen Razavi, Reza Hadavi, Ali Ahmad Bayat, Ali Salimi, Mohammad Mehdi Akhondi, Hodjattallah Rabbani
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2019-06-01
Series:Iranian Journal of Immunology
Subjects:
apoptosis
Chronic lymphocytic leukemia
Fibromodulin (FMOD)
Glycosylphosphatidylinositol
Monoclonal antibody
Online Access:http://iji.sums.ac.ir/article_44938_825b6bb75b89764912d0dbc21960c748.pdf

Internet

http://iji.sums.ac.ir/article_44938_825b6bb75b89764912d0dbc21960c748.pdf

Similar Items